Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recent developments of RNA-based vaccines in cancer immunotherapy.
Faghfuri E, Pourfarzi F, Faghfouri AH, Abdoli Shadbad M, Hajiasgharzadeh K, Baradaran B. Faghfuri E, et al. Among authors: abdoli shadbad m. Expert Opin Biol Ther. 2021 Feb;21(2):201-218. doi: 10.1080/14712598.2020.1815704. Epub 2020 Sep 3. Expert Opin Biol Ther. 2021. PMID: 32842798 Review.
Immune Checkpoints and CAR-T Cells: The Pioneers in Future Cancer Therapies?
Hosseinkhani N, Derakhshani A, Kooshkaki O, Abdoli Shadbad M, Hajiasgharzadeh K, Baghbanzadeh A, Safarpour H, Mokhtarzadeh A, Brunetti O, Yue SC, Silvestris N, Baradaran B. Hosseinkhani N, et al. Among authors: abdoli shadbad m. Int J Mol Sci. 2020 Nov 5;21(21):8305. doi: 10.3390/ijms21218305. Int J Mol Sci. 2020. PMID: 33167514 Free PMC article. Review.
The role of CD44 in cancer chemoresistance: A concise review.
Yaghobi Z, Movassaghpour A, Talebi M, Abdoli Shadbad M, Hajiasgharzadeh K, Pourvahdani S, Baradaran B. Yaghobi Z, et al. Among authors: abdoli shadbad m. Eur J Pharmacol. 2021 Jul 15;903:174147. doi: 10.1016/j.ejphar.2021.174147. Epub 2021 May 5. Eur J Pharmacol. 2021. PMID: 33961871 Review.
A Systematic Review to Clarify the Prognostic Values of CD44 and CD44+CD24- Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead.
Abdoli Shadbad M, Hosseinkhani N, Asadzadeh Z, Derakhshani A, Karim Ahangar N, Hemmat N, Lotfinejad P, Brunetti O, Silvestris N, Baradaran B. Abdoli Shadbad M, et al. Front Oncol. 2021 Aug 9;11:689839. doi: 10.3389/fonc.2021.689839. eCollection 2021. Front Oncol. 2021. PMID: 34434894 Free PMC article.
The expression pattern of VISTA in the PBMCs of relapsing-remitting multiple sclerosis patients: A single-cell RNA sequencing-based study.
Derakhshani A, Asadzadeh Z, Baradaran B, Safarpour H, Rahmani S, Leone P, Abdoli Shadbad M, Hosseinkhani N, Ghasemigol M, Ayromlou H, Ahmadi H, Pouya S, Shojaee M, Tabrizi NJ, Miraki Feriz A, Safarzadeh E, Racanelli V. Derakhshani A, et al. Among authors: abdoli shadbad m. Biomed Pharmacother. 2022 Apr;148:112725. doi: 10.1016/j.biopha.2022.112725. Epub 2022 Feb 17. Biomed Pharmacother. 2022. PMID: 35183994 Free article.
Prognostic Role and Clinical Significance of Tumor-Infiltrating Lymphocyte (TIL) and Programmed Death Ligand 1 (PD-L1) Expression in Triple-Negative Breast Cancer (TNBC): A Systematic Review and Meta-Analysis Study.
Lotfinejad P, Asghari Jafarabadi M, Abdoli Shadbad M, Kazemi T, Pashazadeh F, Sandoghchian Shotorbani S, Jadidi Niaragh F, Baghbanzadeh A, Vahed N, Silvestris N, Baradaran B. Lotfinejad P, et al. Among authors: abdoli shadbad m. Diagnostics (Basel). 2020 Sep 17;10(9):704. doi: 10.3390/diagnostics10090704. Diagnostics (Basel). 2020. PMID: 32957579 Free PMC article. Review.
The oncogenic potential of NANOG: An important cancer induction mediator.
Najafzadeh B, Asadzadeh Z, Motafakker Azad R, Mokhtarzadeh A, Baghbanzadeh A, Alemohammad H, Abdoli Shadbad M, Vasefifar P, Najafi S, Baradaran B. Najafzadeh B, et al. Among authors: abdoli shadbad m. J Cell Physiol. 2021 Apr;236(4):2443-2458. doi: 10.1002/jcp.30063. Epub 2020 Sep 22. J Cell Physiol. 2021. PMID: 32960465 Review.
25 results